- Solutions
Our solutions
- OverviewOur workflow solutions give you the data, tools, and insights to power every decision
- Strategic IntelligenceGet a complete view of strategic issues and stay ahead of emerging disruptive themes
- Sales IntelligenceOur workflow solutions give you the data, tools, and insights to power every decision
- Industry
- Platform
Our platform
Your powerful intelligence platform
Explore the fully comprehensive productivity and insights platform
- Company
We are GlobalData
The integration of advanced technology in the healthcare sector has unlocked new digital health use cases, ranging from telemedicine apps to connected ambulances. GlobalData, a leading data and analytics company, says that telcos can leverage their expertise in technologies such as 5G, Internet of Things (IoT), and artificial intelligence (AI) to enter the growing digital […]
Over $1bn worth of partnership agreements for the ‘Big Six’ Premier League clubs could be at risk, says GlobalData
Following today’s news (Wednesday 21 April) that the proposed European Super League will likely not go ahead; Conrad Wiacek, Head of Sport Analysis at GlobalData, a leading data and analytics company, offers his view on the state of the sponsorship market: “The six Premier League clubs who attempted to breakaway and form a Super League […]
Paul Weiss Rifkind Wharton & Garrison and Willkie Farr & Gallagher were top M&A legal advisers by value and volume in retail sector for Q1 2021, finds GlobalData
Paul Weiss Rifkind Wharton & Garrison and Willkie Farr & Gallagher were the top mergers and acquisitions (M&A) legal advisers in the retail sector for Q1 2021 by value and volume, respectively. Paul Weiss Rifkind Wharton & Garrison advised on five deals worth US$10.7bn, which was the highest value among all the advisers. Meanwhile, Willkie […]
UBS and PwC were top M&A financial advisers by value and volume in retail sector for Q1 2021, finds GlobalData
UBS and PwC were the top mergers and acquisitions (M&A) financial advisers in the retail sector for Q1 2021 by value and volume, respectively. UBS advised on three deals worth US$6.9bn, which was the highest value among all the advisers. Meanwhile, PwC led in volume terms having advised on seven deals worth US$2.6bn. A total […]
Gemtesa is a welcome entrant to US overactive bladder market as it addresses need for safer therapies, says GlobalData
The commercial launch of Urovant Sciences’ first product, Gemtesa (vibegron), a beta 3 adrenergic receptor agonist in the US, addresses overactive bladder (OAB) symptoms by increasing bladder capacity and an unmet need for alternative, safer therapies for US patients, says GlobalData, a leading data and analytics company. In recent years, Urovant has become established as […]
Diagnosed incident cases of melanoma in Canada projected to increase by 23.35% by 2029, says GlobalData
Diagnosed incident cases of melanoma in the eight major markets (8MM*) combined is expected to increase from 0.19 million cases in 2019 to 0.22 million cases in 2029, at an annual growth rate (AGR) of 1.66%, according to GlobalData, a leading data and analytics company. Of the 8MM, the diagnosed incident cases of melanoma in […]
Latham & Watkins, White & Case top M&A legal advisers by value and volume in Middle East & Africa for Q1 2021, finds GlobalData
Latham & Watkins and White & Case were the top mergers and acquisitions (M&A) legal advisers in Middle East & Africa for Q1 2021 by value and volume, respectively. Latham & Watkins advised on four deals worth US$12.6bn, which was the highest value among all the advisers. Meanwhile, White & Case led in volume terms […]
Party package holidays may suffer in post-pandemic travel as young generations turn to adventure holidays, says GlobalData
‘Party package’ holidays were already declining pre-pandemic in terms of both demand and supply. Fears of infection and the process of organizing group travel will further delay recovery. It is likely that demand will never fully return as both individuals and destinations are drifting away from this party concept, says GlobalData, a leading data and […]
Lefosse Advogados, Demarest Advogados top M&A legal advisers by value and volume in South & Central America for Q1 2021, finds GlobalData
Lefosse Advogados and Demarest Advogados were the top mergers and acquisitions (M&A) legal advisers in South & Central America for Q1 2021 by value and volume, respectively. Lefosse Advogados advised on two deals worth US$9.5bn, which was the highest value among all the advisers. Meanwhile, Demarest Advogados led in volume terms having advised on four […]
Jefferies, JP Morgan top M&A financial advisers by value and volume in Middle East & Africa for Q1 2021, finds GlobalData
Jefferies and JP Morgan were the top mergers and acquisitions (M&A) financial advisers in Middle East & Africa for Q1 2021 by value and volume, respectively. Jefferies advised on two deals worth US$10.2bn, which was the highest value among all the advisers. Meanwhile, JP Morgan led in volume terms having advised on six deals worth […]
JP Morgan top M&A financial adviser by value and volume in South & Central America for Q1 2021, finds GlobalData
JP Morgan was the top mergers and acquisitions (M&A) financial adviser in South & Central America for Q1 2021 by both value and volume. JP Morgan advised on three deals worth US$9.7bn, which was the highest value among all the advisers. A total of 190 M&A deals were announced in the region during Q1 2021, […]
Immuno-oncology will be dominant class of drugs for hepatocellular carcinoma by 2029, says GlobalData
Immuno-oncology (IO) agents will be the dominant class in the hepatocellular carcinoma (HCC) market by 2029 due to the launch of pipeline drugs targeting programmed cell death protein 1 (PD-1) or programmed death-ligand 1 (PD-L1) and cytotoxic T-lymphocyte-associated protein 4 (CTLA-4), which will constitute a large proportion of prescriptions as they will be used as […]
Pfizer/BioNTech’s vaccine predicted record-breaking sales of $24.8bn by 2021, says GlobalData
Pfizer/BioNTech’s Comirnaty (tozinameran) is forecast to have peak sales of $24.8bn by 2021, which is only its second year on the market. This is a 20% increase over Humira’s peak sales of $20.5bn, suggesting that Comirnaty could be the next top drug by peak sales within only two years of its launch, says GlobalData, a […]
Goldman Sachs top M&A financial adviser in North America for Q1 2021, finds GlobalData
Goldman Sachs emerged as the top financial adviser for mergers and acquisitions (M&A) by both value and volume in North America for Q1 2021, having advised on 84 deals worth US$184.3bn. A total of 3,927 M&A deals were announced in the region during Q1 2021, finds GlobalData, a leading data and analytics company. According to […]
Delayed FDA reviews may signal trouble for JAK inhibitors in autoimmune space, says GlobalData
Five delays in regulatory reviews for a single drug class in less than one month could serve as an early warning sign that the Food and Drug Administration (FDA) is cracking down on safety signals in Janus kinase (JAK) inhibitors and will continue to keep a close eye on these drugs, says GlobalData, a leading […]
Amgen’s $1.9bn bet on Five Prime Therapeutics will require more than one label for bemarituzumab to pay off, says GlobalData
Following today’s news (16 April) that Amgen has completed its planned acquisition of Five Prime Therapeutics for $1.9bn; Sakis Paliouras, PhD, Senior Oncology & Hematology Analyst at GlobalData, a leading data and analytics company, offers his view: “Amgen’s main interest in Five Prime’s pipeline was the lead, first-in-class anti-FGFR2b inhibitor bemarituzumab tested in gastric (GC) […]
Poland set to surpass 2030 solar PV installation target, says GlobalData
Solar photovoltaic (PV) accounted for 8.1% of Poland’s total power capacity in 2020 and this is estimated to reach 21% in 2030. GlobalData, a leading data and analytics company, estimates that Poland will have renewable power capacity of around 33.7 GW by 2030, of which 14.5 GW capacity will be solar photovoltaic (PV). Poland’s current […]
Positive long-term data from Roche’s Evrysdi will consolidate its strong position in SMA market, says GlobalData
Following Roche’s announcement of new 2-year data from Part 2 of FIREFISH, a Phase II/III global study evaluating Evrysdi (risdiplam) in infants aged 1-7 months at enrollment with symptomatic Type 1 spinal muscular atrophy (SMA); Alessio Brunello, Managing Analyst at GlobalData, a leading data and analytics company, offers his view: “Roche’s Evrysdi continues to improve […]
Nigeria to account for 23% of upcoming oil and gas projects in Africa by 2025, says GlobalData
Nigeria is expected to have 100 oil and gas projects commencing operations across the value chain between 2021 and 2025, accounting for 23% of the total project starts in Africa. New build projects dominate the upcoming projects and account for around 90% of the total projects commencing operations across the value chain, according to GlobalData, […]
Eastern Europe’s construction output set to increase by 3.6% in 2021, says GlobalData
Eastern Europe’s construction industry is forecasted to grow by 3.6% in 2021, following a 1.6% contraction in 2020 due to the COVID-19 outbreak and subsequent lockdown restrictions, according to GlobalData, a leading data and analytics company. According to GlobalData’s report, ‘Global Construction Outlook to 2025, Q1 Update’, with the vaccination rollout programme starting across much […]